Author:
Little E C,Camp E R,Wang C,Watson P M,Watson D K,Cole D J
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology
Reference43 articles.
1. National Cancer Institute Pancreatic Cancer Treatment PDQ. Available from
http://www.cancer.gov/cancertopics/pdq/treatment/pancreatic/healthprofessional
2010.
2. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403–2413.
3. Thota R, Pauff JM, Berlin JD . Treatment of metastatic pancreatic adenocarcinoma: a review. Oncology (Williston Park) 2014; 28: 70–74.
4. Arshad A, Al-Leswas D, Al-Taan O, Stephenson J, Metcalfe M, Steward WP et al. Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancer. Am J Clin Oncol 2011; 36: 411–414.
5. Shi S, Yao W, Xu J, Long J, Liu C, Yu X . Combinational therapy: new hope for pancreatic cancer? Cancer Lett 2012; 317: 127–135.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献